On November 9, 2020 Professor Thierry de Baere and his team at Gustave Roussy Hospital (Therapeutic Imaging Department) successfully treated a patient with liver tumor on an outpatient basis using Quantum Surgical’s Epione® medical robot.
“Minimally invasive” interventions, which involves, among other factors, smaller incisions and adapted anesthesia methods compared to the so-called “conventional” procedures, reduces postoperative risks and patients, in turn, see a shorter recovery time. Outpatient surgery allows a person to return home on the same day that a surgical procedure is performed. The development of outpatient interventions is a real step forward in terms of quality of care for patients. Unfortunately, this procedure is still not sufficiently developed in the World even though it could be convenient for many patients.
The Epione® platform aims to increase the number of patients who can benefit from percutaneous ablation of liver tumors (a minimally invasive treatment in which a needle is inserted through the skin to the lesion to burn it). The first ambulatory patient treated with the assistance of Epione® is a key milestone for Quantum Surgical, as it illustrates the potential of its technology to contribute to value-based medicine through the development of outpatient care.
“It is always an immense pleasure and pride to work with a partner recognized as one of the best cancer hospitals in the world and to contribute with our technology to the development of outpatient care” explains Bertin Nahum, President, and co-founder of Quantum Surgical.
About Gustave Roussy:
Gustave Roussy is the premier European Cancer Centre. It is a centre for patient care, research and teaching, and patients with all types of cancer can be treated there. Gustave Roussy places innovation at the heart of a human, scientific and technological revolution in the fight against cancer.
Further information can be found on our website: www.gustaveroussy.fr
Quantum Surgical in a few words:
Co-founded in 2017 by Bertin Nahum, Quantum Surgical is an innovative surgical robotic company based in Montpellier (France). Quantum Surgical’s robotic solution is a combination of powerful software and robotic platform for minimally invasive therapies in liver cancer. This platform combining robotics, image analytics, and artificial intelligence will allow more and more patients to benefit from safer interventional oncology procedures, especially in the case of early-stage liver cancers. The incidence of liver cancer in the population is, unfortunately, growing very rapidly. Liver cancer is one of the most common cancers with more than 800 000 cases each year in the world.
Further information is available on our website: https://quantumsurgical.com